Redsense Medical AB (publ) (RDSNF)
OTCMKTS · Delayed Price · Currency is USD
0.5100
-0.5400 (-51.43%)
At close: Aug 2, 2024
Redsense Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 16.01 | 15.36 | 6.97 | 3.67 | 4.98 | 29.01 | Upgrade |
Short-Term Investments | - | - | - | 6.91 | 21.97 | 36.02 | Upgrade |
Cash & Short-Term Investments | 16.01 | 15.36 | 6.97 | 10.58 | 26.95 | 65.02 | Upgrade |
Cash Growth | 324.58% | 120.44% | -34.16% | -60.74% | -58.55% | 647.81% | Upgrade |
Accounts Receivable | 1.53 | 6.1 | 2.97 | 4.93 | 3.53 | 2.09 | Upgrade |
Other Receivables | 0.1 | 0.41 | 1.76 | 0.33 | 0.67 | 0.89 | Upgrade |
Receivables | 1.63 | 6.51 | 4.72 | 5.26 | 4.2 | 2.98 | Upgrade |
Inventory | 7.42 | 5.99 | 1.36 | 1.53 | 1.38 | 2.34 | Upgrade |
Prepaid Expenses | 0.7 | 0.14 | 0.2 | 0.64 | 0.41 | 0.4 | Upgrade |
Total Current Assets | 25.77 | 27.99 | 13.24 | 18.01 | 32.94 | 70.73 | Upgrade |
Property, Plant & Equipment | 0.29 | 0.31 | 0.36 | 0.37 | 0.37 | 2 | Upgrade |
Long-Term Investments | - | - | - | - | - | 0.2 | Upgrade |
Long-Term Deferred Charges | 13.61 | 13.5 | 12.91 | 12.35 | 9.94 | 5.77 | Upgrade |
Other Long-Term Assets | - | - | 0 | -0 | - | - | Upgrade |
Total Assets | 39.66 | 41.8 | 26.51 | 30.73 | 43.25 | 78.7 | Upgrade |
Accounts Payable | 0.65 | 0.52 | 1.75 | 0.98 | 1.33 | 3.72 | Upgrade |
Accrued Expenses | 1.17 | 1.23 | 1.36 | 2.14 | 0.84 | 1.26 | Upgrade |
Other Current Liabilities | 0.4 | 0.46 | 0.31 | 0.47 | 1.02 | 0.53 | Upgrade |
Total Current Liabilities | 2.21 | 2.21 | 3.41 | 3.58 | 3.19 | 5.51 | Upgrade |
Long-Term Debt | - | - | - | - | 2.57 | - | Upgrade |
Other Long-Term Liabilities | - | 0 | - | - | - | - | Upgrade |
Total Liabilities | 2.21 | 2.21 | 3.41 | 3.58 | 5.76 | 5.51 | Upgrade |
Common Stock | 1.64 | 1.64 | 1.4 | 1.4 | 1.4 | 1.4 | Upgrade |
Additional Paid-In Capital | - | - | - | - | 123.63 | 123.14 | Upgrade |
Retained Earnings | 35.8 | 37.94 | 21.69 | 25.75 | -87.54 | -51.35 | Upgrade |
Comprehensive Income & Other | - | 0 | - | - | 0 | - | Upgrade |
Shareholders' Equity | 37.45 | 39.59 | 23.1 | 27.15 | 37.49 | 73.2 | Upgrade |
Total Liabilities & Equity | 39.66 | 41.8 | 26.51 | 30.73 | 43.25 | 78.7 | Upgrade |
Total Debt | - | - | - | - | 2.57 | - | Upgrade |
Net Cash (Debt) | 16.01 | 15.36 | 6.97 | 10.58 | 24.38 | 65.02 | Upgrade |
Net Cash Growth | 324.58% | 120.44% | -34.16% | -56.60% | -62.51% | 777.77% | Upgrade |
Net Cash Per Share | 0.90 | 0.90 | 0.49 | 0.75 | 1.74 | 4.63 | Upgrade |
Filing Date Shares Outstanding | 16.44 | 16.44 | 14.04 | 14.04 | 14.04 | 14.04 | Upgrade |
Total Common Shares Outstanding | 16.44 | 16.44 | 14.04 | 14.04 | 14.04 | 14.04 | Upgrade |
Working Capital | 23.55 | 25.78 | 9.83 | 14.43 | 29.75 | 65.23 | Upgrade |
Book Value Per Share | 2.28 | 2.41 | 1.64 | 1.93 | 2.67 | 5.21 | Upgrade |
Tangible Book Value | 37.45 | 39.59 | 23.1 | 27.15 | 37.49 | 73.2 | Upgrade |
Tangible Book Value Per Share | 2.28 | 2.41 | 1.64 | 1.93 | 2.67 | 5.21 | Upgrade |
Machinery | - | 0.55 | 0.53 | 0.48 | 0.43 | 2.05 | Upgrade |
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.